Hjem › Gliom › Texas › Houston
Kliniske studier for Gliom i Houston, TX
23 studier for Gliom søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RekruttererFase 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekruttererFase 1/2
- Baylor College of Medicine, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
RekruttererFase 1
- M D Anderson Cancer Center, Houston
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RekruttererFase 2
- Texas Children's Hospital, Houston
MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Rekrutterer
- M D Anderson Cancer Center, Houston
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
RekruttererObservasjonsstudie
- M D Anderson Cancer Center, Houston
Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
RekruttererFase 1
- The University of Texas M. D. Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
RekruttererObservasjonsstudie
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RekruttererFase 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
RekruttererFase 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RekruttererFase 3
- MD Anderson Cancer Center, Houston
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RekruttererFase 2
- Texas Children's Hospital, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
RekruttererObservasjonsstudie
- M D Anderson Cancer Center, Houston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekruttererFase 1/2
- Research Site, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
RekruttererFase 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
RekruttererFase 1
- Texas Children's Hospital, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- University of Texas MD Anderson Cancer Center, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
- Texas Children's Hospital, Houston
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
RekruttererTidlig fase 1
- M D Anderson Cancer Center, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RekruttererFase 2
- Texas Children's Hospital, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
RekruttererFase 1
- MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RekruttererTidlig fase 1
- Texas Children's Hospital, Houston
Gliom-studier i andre byer
- New York City, NY25 studier
- Boston, MA20 studier
- Washington, DC19 studier
- Philadelphia, PA16 studier
- Miami, FL15 studier
- Columbus, OH15 studier
- San Francisco, CA14 studier
- Chicago, IL13 studier
- Durham, NC12 studier
- Seattle, WA11 studier
- Los Angeles, CA10 studier
- St. Louis, MO10 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.